Post Market Surveys: Insights from the poolside

Why real-world evidence might just be your device's secret summer superpower

Authored by Ellie Baker, Commercial Director

As MedTech professionals know, the industry rarely sleeps but let’s be honest, in August, it definitely takes a nap. With inboxes a little quieter and decision-makers (hopefully) stealing a few hours in the sun, it’s the perfect time for some lighter reflection. So, grab your iced coffee (or something stronger), and let’s talk Post Market Surveys, from the poolside.


What are Post Market Surveys? 

At their core, Post Market Surveys offer MedTech companies a cost-effective way to gather Real World Clinical Data. Once a device is on the market, these surveys are commonly used to collect safety and performance data to support regulatory submissions, such as PMCF and PMPF under the EU-MDR and IVDR. But their value extends beyond compliance; other uses include informing on label and indication expansion.

And for devices that fall under Article 61(10), where pre-market clinical data is limited, PMCF surveys can become not just helpful, but essential.

Why partner with Purdie Pascoe? 

Since 2019, we’ve delivered 400+ Post Market Surveys across a wide range of device types and risk classifications, collecting both Level 4 and Level 8 data. But what truly sets us apart is the unique combination of regulatory insight and market research expertise. We don’t just meet compliance requirements, Purdie Pascoe has a dedicated primary market research team, specialising in MedTech. We therefore don’t just meet compliance requirements, our market reseach expertise helps with the design of our surveys and engagement of HCPs. 

Whether you need end-to-end support or just help with specific elements, such as survey design, data collection, or reporting; we offer flexible solutions to match your needs. Our team of experts can turn your objectives into actionable survey questions, compliance and everything else that ensures smooth sailing. 

Case study spotlight: Expanding a device’s indication — with 100% success

One of our favourite recent projects: Helping a client explore a new indication for their device based on promising user feedback.

The device was originally designed for a specific indication, but clinicians began using it off-label, noting positive outcomes. The client wanted to explore this potential and support an IFU expansion. We helped them collect real-world data from 30 retrospective cases across the US to back the case with evidence.

The result?

  • 100% procedural success rate

  • No device or procedure-related complications

  • Label expansion supported with solid, regulatory-ready data

This wasn’t a PMCF survey in the traditional sense, but it shows how real-world data collected smartly and ethically, can support commercial strategy, not just compliance.

Poolside takeaways from the RAPS Euro Convergence 

At RAPS EU earlier this summer, one thing was crystal clear: real world data collection is no longer just an option. Regulators in the EU, US, and China are placing more weight on real-world evidence, and sharing data across borders is increasingly valuable. 

Another hot topic? Article 61(10); especially for devices where pre-market clinical data is difficult to collect. Post Market surveys are proving an effective strategy to bridge that gap and maintain compliance while keeping innovation alive. Want to learn more? We recently hosted a live webinar with  BSI ‘Article 61(10) within the EU MDR | Notified Body insights and the role of PMCF Surveys’. Watch the webcast here.  

For SMEs, where resources are tighter and Notified Body capacity remains a challenge, partnering with Post Market Survey experts is more important than ever. 


Final thoughts: Stay cool, stay compliant 

Whether you're reviewing clinical endpoints or which sunbed to choose, it's worth remembering that regulatory progress doesn’t have to be dry or daunting. With the right partner, Post Market Surveys can provide powerful data that keeps your device safe, effective, and ultimately on the market.

So, this summer, while things slow down just a little, it’s the perfect time to think strategically. If you're considering a PMCF or PMPF survey or just want to discuss what’s possible with real-world data, the Purdie Pascoe team is always happy to talk (ideally with sunglasses on).


Want to learn more?

Explore our services via the button below, or contact our team directly here.

Next
Next

Spotlight on MedTech end-to-end solutions